Search Results

Sustained response of galcanezumab in migraine prevention: Patient‐level data from a post hoc analysis in patients with episodic or chronic migraine.

• Authors : Tepper, Stewart J.; Dong, Yan; Vincent, Maurice

Subjects: MIGRAINE prevention; THERAPEUTIC use of monoclonal antibodies; DRUG efficacy

• Source: Headache: The Journal of Head & Face Pain. Nov2023, Vol. 63 Issue 10, p1380-1390. 11p.

Record details

Monoclonal antibodies for treating early Alzheimer disease—a commentary on recent 'positive' trials.

• Authors : Scott, Ian A

Subjects: ALZHEIMER'S disease prevention; THERAPEUTIC use of monoclonal antibodies; DRUG efficacy

• Source: Age & Ageing; Feb2024, Vol. 53 Issue 2, p1-10, 10p

Record details

COVID-19 Pre-Exposure Prophylaxis.

Subjects: *THERAPEUTIC use of monoclonal antibodies; *DRUG efficacy; *COMBINATION drug therapy

• Source: Infectious Disease Alert. Jun2022, Vol. 41 Issue 9, p1-2. 2p.

Record details

The prevention of osteoporosis and sarcopenia in older adults.

• Authors : Coll, Patrick P. (AUTHOR); Phu, Steven (AUTHOR); Hajjar, Samah H. (AUTHOR)

Subjects: OSTEOPOROSIS prevention; THERAPEUTIC use of monoclonal antibodies; SKELETAL muscle

• Source: Journal of the American Geriatrics Society. May2021, Vol. 69 Issue 5, p1388-1398. 11p.

Record details

Patient‐identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient‐centered outcome.

• Authors : Lipton, Richard B.; Dodick, David W.; Ailani, Jessica

Subjects: MIGRAINE prevention; THERAPEUTIC use of monoclonal antibodies; STATISTICS

• Source: Headache: The Journal of Head & Face Pain. May2021, Vol. 61 Issue 5, p766-776. 11p.

Record details

Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies

• Authors : Smitherman, Todd A.; Tietjen, Gretchen E.; Schuh, Kory

Subjects: MIGRAINE prevention; THERAPEUTIC use of monoclonal antibodies; ANXIETY

• Source: Headache: The Journal of Head & Face Pain. Nov2020, Vol. 60 Issue 10, p2202-2219. 18p.

Record details

Combination CGRP monoclonal antibody and onabotulinumtoxinA treatment for preventive treatment in chronic migraine.

• Authors : Ailani, Jessica; Blumenfeld, Andrew M.

Subjects: THERAPEUTIC use of monoclonal antibodies; BOTULINUM toxin; COMBINATION drug therapy

• Source: Headache: The Journal of Head & Face Pain. Jan2022, Vol. 62 Issue 1, p106-108. 3p.

Record details

Emerging Options for Malaria Prevention.

Subjects: *MALARIA prevention; *THERAPEUTIC use of monoclonal antibodies; *DRUG efficacy

• Source: Infectious Disease Alert. Oct2021, Vol. 41 Issue 1, p1-3. 3p.

Record details

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine.

• Authors : Berman, Gary; Croop, Robert; Kudrow, David

Subjects: THERAPEUTIC use of monoclonal antibodies; ANALGESICS; COMBINATION drug therapy

• Source: Headache: The Journal of Head & Face Pain. Sep2020, Vol. 60 Issue 8, p1734-1742. 9p.

Record details

Considering use of teprotumumab in thyroid eye disease patients: There is need for alternative treatment to circumvent current treatment limitations.

• Authors : Pascoe, Alexis¹ ; Baig, Iyza F.¹ ; Lee, Andrew G.^2,3,4,5,6

Subjects: *THERAPEUTIC use of monoclonal antibodies; *DIPLOPIA; *EXOPHTHALMOS

• Source: Ophthalmology Times. 10/1/2018, Vol. 43 Issue 16, p24-26. 2p.

Record details